Wikipedia -WSS

Wikipedia

author：knowledge 2025-09-28 07:07:51 - browse：96

From 2017 to 2020, Stimwave implanted nearly 8,000 patients with nerve stimulators containing dummy pieces of plastic. Adobe

The Securities and Exchange Commission on Tuesday charged the former CEO of Stimwave, a company that sold devices containing dummy pieces of plastic, with defrauding investors out of $41 million.

Laura Perryman led Stimwave, which sold nerve stimulation devices to combat pain, from 2010 to 2019, when the fraud came to light. Under her leadership, Stimwave warped the design of the device to better align with insurance codes, resulting in unnecessary plastic components that allowed the company to sell their products for thousands of dollars more than they otherwise could. From 2017 to 2020, the company implanted nearly 8,000 patients with these devices.

STAT published new details about the Stimwave story in May, learning from former employees that Perryman broke into Stimwave’s Florida headquarters to steal back devices after her termination in 2019. The fraud laid bare the limits of the Food and Drug Administration’s device surveillance system, doctors’ ability to scrutinize device effectiveness, and how impossible it is for patients to get answers about the implants they receive.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Anesthesiologist group: stop taking Ozempic before surgery
Next article： Study: Black kids more likely to die after surgery than white kids

focus

hotspot

WSS

Overprescribed: High cost isn't America's only drug problem

Scientific mystery highlights the blind spots in genomics databases

Virtual care provider acquires bankrupt Pear's prescription apps

Harvard scientists, with Google, unveil the most detailed brain map ever

Hundreds died while taking an arthritis drug, but nobody alerted patients

Four alarming medical procedures we’re glad history forgot

knowledge

Wikipedia

explore

How one medical school became remarkably diverse

Albert Bourla of Pfizer: worst biopharma CEO of 2023

Supreme Court strikes down use of affirmative action

Trial using CRISPR to edit HIV out of cells disappoints

ChatGPT in medicine: STAT answers readers' burning questions

Scientific mystery highlights the blind spots in genomics databases

Affirmative action in medical school literally saved lives

Oral obesity drug from Viking Therapeutics hits key early target

Medical records are filled with copy

Depression: FDA OKs Otsuka Pharmaceuticals digital therapeutic

focus

Overprescribed: High cost isn't America's only drug problem

Keeping primary care docs in field isn't impossible, says AAFP CEO

First Opinion on colorectal cancer screening: letter and response

Prime Medicine, Myeloid Therapeutics clash over genome

Humana’s Medicare Advantage lawsuit should be tossed, DOJ says

SNAP should offer more nutrition education

knowledge

focus

hotspot

focus